December 4 - 8, 2022
Marriott Marquis San Diego,
Delivered as a Hybrid Event
THE #1 ANTIBODY ENGINEERING CONFERENCE FOR ACCELERATING NEXT GENERATION ANTIBODIES TO COMMERCIAL SUCCESS
Call for Speakers and Early-Reg Now Open for 2022!
Early Confirmed Keynote Speakers for 2022
Celebrating 33 Years of Bringing The Community Together to Discuss Time-Critical Antibody Engineering Updates and Best Practices
Brand New Session Themes for 2022:
- Antibody engineering, libraries and selection (including HTS)
- Machine learning/artificial intelligence in antibody discovery and engineering
- Fc-engineering & other (non IgG1/IgG4) subclasses
- Antibody-drug conjugates, toxins and other conjugates
- Cellular therapies: CART's (T and NK) (non-cell engaging)
- Bispecifics / multispecifics / combinations (non-cell engaging)
- Antibodies in Infectious diseases
- T cell (including gamma/delta) and NK cell engagers
Brand New Session Themes for 2022:
- Advancing antibody therapeutics in immuno-oncology
- Tumor microenvironment (including immunocytokines)
- Novel/difficult targets for antibody therapeutics (e.g. MHCp, GPRC, glycans etc)
- How to develop an antibody-based drug: from discovery to IND?
- Adaptive immune receptor repertoire data processing, annotation and interpretation
- Antibodies in non-cancer (Autoimmune, neurological and other diseases)
- Functional Screening Integrated Into Initial Antibody Discovery
3 Unmissable Add-On Options
Extend your learning even further with 3 vital add-on options designed to embed your knowledge prior to the main conference.
Options include:
- Pre-Conference Half-Day Workshop A (PM): How to Develop an Antibody-based Drug from Discovery to IND?
- Pre-Conference Half-Day Workshop B (PM): Adaptive Immune Receptor Repertoire Data Processing, Annotation and Interpretation
- Pre-Conference Full-Day Training Course: Introduction to Antibody Engineering
Get the latest news.
As it happens
Put Yourself Infront Of Key Antibody Decision-Makers!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Blake Shuka
blake.shuka@informa.com | (+1) 212-600-3451
About the Antibody Society
The Antibody Society is an international, non-profit representing individuals and organizations involved in antibody-related research and development. The Society has a variety of initiatives and working groups focused on improving the antibody field.
We are:
- Creating opportunities for education and networking;
- Monitoring and reporting advances in the commercial pipeline for antibody and CAR-T therapeutics;
- Creating standards for characterizing antibody and T-cell receptor repertoires, and engaging this field;
- Engaging government and international agencies on matters concerning the antibody community;
Please join us!
Informa AllSecure is Informa’s approach to enhanced health and safety standards at our events following COVID-19
